Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7

Wei A He1, Federica Calore, Priya Londhe

  • 1Department of Molecular Virology, Immunology, and Medical Genetics, Human Cancer Genetics Program, and the Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210.

Insights

Tumor cells release microvesicles containing microRNA-21 (miR-21), which induce skeletal muscle cell death. This pathway, involving Toll-like receptor 7 (TLR7) and c-Jun N-terminal kinase, contributes to cancer cachexia and muscle loss.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Cancer cachexia involves significant skeletal muscle mass loss, partly due to apoptosis.
  • The mechanisms by which tumors induce apoptosis in distant skeletal muscles remain largely unexplored.

Purpose of the Study:

  • To investigate how tumors induce apoptosis in skeletal muscle cells.
  • To identify the molecular mediators responsible for tumor-induced muscle wasting.

Main Methods:

  • Utilized tumor cell lines and patient samples.
  • Analyzed the role of tumor-derived microvesicles and specific microRNAs (miRNAs).
  • Investigated signaling pathways including Toll-like receptor 7 (TLR7) and c-Jun N-terminal kinase (JNK).

Main Results:

  • Tumor-derived microvesicles were shown to induce apoptosis in skeletal muscle cells.
  • MicroRNA-21 (miR-21) within these microvesicles mediates the proapoptotic effect.
  • The miR-21/TLR7 pathway and JNK activity are crucial for this tumor-induced muscle cell death.

Conclusions:

  • A novel pathway is described where tumor cells promote muscle loss via secreted microvesicles carrying miR-21.
  • This finding offers insights into the pathogenesis of cancer cachexia.
  • Identified potential targets for therapeutic interventions against cancer-related muscle wasting.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K